Microbix Biosystems Set to Present at Muskoka Capital Event
Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF), a prominent player in the life sciences sector based in Mississauga, is excited to announce its participation in the Muskoka Capital Event. This event, organized by Capital Event Management Ltd., will take place at the JW Marriott Rosseau Muskoka in Ontario, providing a platform for meaningful dialogue between investors and industry leaders.
Details of the Muskoka Capital Event
The Muskoka Capital Event, scheduled from September 26 to 28, aims to foster relationships among investors, public, and private companies. During this gathering, CEO Cameron Groome and COO Ken Hughes will conduct 18 one-on-one meetings with growth-focused investors, highlighting Microbix's innovative contributions to the life sciences sector.
Engagement with the Investor Community
Throughout the event, executives from Microbix will present insightful discussions regarding the company’s growth strategies and innovations. Attendees can expect to gain a deeper understanding of Microbix's products and mission. The presentation materials will be made available on Microbix’s official website for wider access post-event.
About Microbix Biosystems Inc.
Microbix is at the forefront of developing proprietary biological products that enhance human health. The company has built a strong reputation for creating critical ingredients for the diagnostics industry. With over 120 skilled professionals, Microbix generates monthly revenues exceeding C$ 2.0 million, positioning itself as a significant contributor to global health advancements.
Innovative Products and Technologies
The company's diverse portfolio includes antigens for immunoassays, essential laboratory quality assessment products (QAPs™), and reference materials (QUANTDx™). These products play a pivotal role in supporting point-of-care testing and clinical laboratory quality assurance strategies, thus assuring the quality of diagnostic workflows and facilitating assay development.
Global Reach and Compliance
Microbix has extended its market reach to over 30 countries globally, bolstered by strategic partnerships with international distributors. The company holds multiple industry certifications, including ISO 9001 and 13485 accreditations, and is recognized by U.S. FDA and Australian TGA. This compliance ensures that its products meet rigorous international standards.
Expanding Horizons in Health Solutions
Beyond diagnostics, Microbix utilizes its expertise to develop groundbreaking treatments like Kinlytic® urokinase, a biologic drug targeting blood clots. Moreover, the company offers reagents and media to support molecular diagnostic testing, ensuring it remains at the cutting edge of the health technology landscape.
Microbix's Commitment to Investors
Engagement with investors is a cornerstone of Microbix’s growth strategy. The Muskoka Capital Event represents a unique opportunity for the company to strengthen its investor relations. By showcasing products and innovations directly to potential investors, Microbix aims to foster transparency and build a solid foundation for future growth.
Contact Information for Inquiries
For those interested in learning more about Microbix or its offerings, the company can be reached at:
Cameron Groome, CEO
(905) 361-8910
Jim Currie, CFO
(905) 361-8910
Deborah Honig, Investor Relations
Adelaide Capital Markets
(647) 203-8793
ir@microbix.com
Frequently Asked Questions
What is the Muskoka Capital Event?
The Muskoka Capital Event is an investor event where companies present their innovations and strategies, fostering relationships with investors.
Who will represent Microbix at the event?
CEO Cameron Groome and COO Ken Hughes will represent Microbix during the event.
What are Microbix's key products?
Microbix produces biological products for diagnostics, including antigens, QAPs™, and QUANTDx™.
How does Microbix ensure product quality?
The company is ISO 9001 and 13485 certified, U.S. FDA registered, and adheres to international compliance standards.
Where can I find more information about Microbix?
Further information can be found on Microbix's official website, where they publish news and financial disclosures.
